Records 1 - 5
| MTRR rs1801394 and its interaction with MTHFR rs1801133 in colorectal cancer: a case-control study and meta-analysis.
Pharmacogenomics 2017 Jul .
Haerian Monir Sadat, Haerian Batoul Sadat, Molanaei Saadat, Kosari Farid, Sabeti Shahram, Bidari-Zerehpoosh Farahnaz, Abdolali Ebrah
| Associations of the A66G Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Biomarkers in cancer 2015 7 (Suppl 1): 21-8.
Pabalan Noel, Singian Eloisa, Tabangay Lani, Jarjanazi Hamdi, Singh Nee
| The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer.
International journal of biological sciences 2012 8 (6): 819-30.
Zhou Daijun, Mei Qiang, Luo Han, Tang Bo, Yu Pei
| Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.
Molecular biology reports 2011 May .
Han D, Shen C, Meng X, Bai J, Chen F, Yu Y, Jin Y, Fu S
| A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 20 (3): 918-22.
Wu Ping-Ping, Tang Ri-Ning, An